Episode 8 | David Fajgenbaum: Surviving Castleman Disease and Reinventing Drug Discovery with AI
Precision Signals
Episode 8 | David Fajgenbaum: Surviving Castleman Disease and Reinventing Drug Discovery with AI
56:14
Why Sean Parker Took on Cancer: Funding Risk, Failure, and Real Progress
Precision Signals
Why Sean Parker Took on Cancer: Funding Risk, Failure, and Real Progress
5:30
The High Cost of Randomized Trials for Companies #shorts
Precision Signals
The High Cost of Randomized Trials for Companies #shorts
1:56
Episode 7 | Sushil Patel, CEO of Replimune: The Future of Cancer Immunotherapy
Precision Signals
Episode 7 | Sushil Patel, CEO of Replimune: The Future of Cancer Immunotherapy
1:08:31
Digital Twins and Synthetic Control Arms #shorts
Precision Signals
Digital Twins and Synthetic Control Arms #shorts
1:18
Funding High-Risk High-Reward Science: Venture Capital Meets Philanthropy
Precision Signals
Funding High-Risk High-Reward Science: Venture Capital Meets Philanthropy
4:10
Emerson Collective: Unique Model for Impact #shorts
Precision Signals
Emerson Collective: Unique Model for Impact #shorts
1:20
Yosemite: Funding Cancer Innovation with Philanthropy & VC #shorts
Precision Signals
Yosemite: Funding Cancer Innovation with Philanthropy & VC #shorts
1:14
Future of Cancer Therapeutics: Emerging Modalities #shorts
Precision Signals
Future of Cancer Therapeutics: Emerging Modalities #shorts
1:20
Episode 6 | Dan McHugh: From Bench to Boardroom
Precision Signals
Episode 6 | Dan McHugh: From Bench to Boardroom
1:05:05
Sean Parker Institute Speeds Up Cancer Treatments #shorts
Precision Signals
Sean Parker Institute Speeds Up Cancer Treatments #shorts
0:20
Precision Oncology: Cancer Care in 5 Years? #shorts
Precision Signals
Precision Oncology: Cancer Care in 5 Years? #shorts
0:53
Ep. 5: Leading at Every Altitude: Karen Knudsen, PhD, MBA
Precision Signals
Ep. 5: Leading at Every Altitude: Karen Knudsen, PhD, MBA
1:08:11
Zhen Su, MD, MBA on Hidden Cost Barrier Slowing Down Oncology Innovation @Shorts ·
Precision Signals
Zhen Su, MD, MBA on Hidden Cost Barrier Slowing Down Oncology Innovation @Shorts ·
1:39
Josh Bilenker on Biotech’s Structural Pressures #shorts
Precision Signals
Josh Bilenker on Biotech’s Structural Pressures #shorts
1:29
AI Agents Are Transforming Clinical Research | Michelle Longmire on Precision Signals
Precision Signals
AI Agents Are Transforming Clinical Research | Michelle Longmire on Precision Signals
2:28
Why Cancer Drug Approvals Don't Match Clinical Reality #shorts
Precision Signals
Why Cancer Drug Approvals Don't Match Clinical Reality #shorts
1:52
Lloyd Minor: AI Is Transforming Medicine—If We Let It
Precision Signals
Lloyd Minor: AI Is Transforming Medicine—If We Let It
0:42
Merc KGaA CEO Belén Garijo on the Power of Big Data in Cancer Research #shorts
Precision Signals
Merc KGaA CEO Belén Garijo on the Power of Big Data in Cancer Research #shorts
3:00
Stanford Professor's Stage 4 Cancer Fight: A Personal Story #shorts
Precision Signals
Stanford Professor's Stage 4 Cancer Fight: A Personal Story #shorts
2:03
FDA’s New Framework: Replacing Animal Testing with Computation and AI #shorts
Precision Signals
FDA’s New Framework: Replacing Animal Testing with Computation and AI #shorts
1:51
Mars Mission Mindset: Transform Healthcare with Radical Ideas
Precision Signals
Mars Mission Mindset: Transform Healthcare with Radical Ideas
1:15
Coach K on Leadership: “You Don’t Win Alone” #shorts
Precision Signals
Coach K on Leadership: “You Don’t Win Alone” #shorts
1:05
Healthcare Crisis: Why The System is Bankrupting America #shorts
Precision Signals
Healthcare Crisis: Why The System is Bankrupting America #shorts
0:55
James Gulley, MD, PhD: The Architecture of Evidence in Immuno-Oncology
Precision Signals
James Gulley, MD, PhD: The Architecture of Evidence in Immuno-Oncology
2:09
You Can't Win Alone
Precision Signals
You Can't Win Alone
4:19
Everything is Changing Everywhere
Precision Signals
Everything is Changing Everywhere
1:35
Everything Is Changing Everywhere | Daniel Arbess on Institutional Innovation in Healthcare | Ep. 4
Precision Signals
Everything Is Changing Everywhere | Daniel Arbess on Institutional Innovation in Healthcare | Ep. 4
49:31
Dr. James Gulley on 100 New Immunotherapies in 10 Years #Immunotherapy #CancerResearch #shorts
Precision Signals
Dr. James Gulley on 100 New Immunotherapies in 10 Years #Immunotherapy #CancerResearch #shorts
0:48
James Gulley, MD, PhD: The Architecture of Evidence in Immuno-Oncology, Episode 3.
Precision Signals
James Gulley, MD, PhD: The Architecture of Evidence in Immuno-Oncology, Episode 3.
53:18
FDA Incentives Could Redefine Precision Medicine #shorts #fda #oncology #drugdevelopment
Precision Signals
FDA Incentives Could Redefine Precision Medicine #shorts #fda #oncology #drugdevelopment
0:53
Agentic AI in Clinical Trials #shorts #innovation #ai #clinicaltrials
Precision Signals
Agentic AI in Clinical Trials #shorts #innovation #ai #clinicaltrials
0:59
Episode 3 Preview: Daniel Arbess on Purpose, Investment, and the Future of Healthcare
Precision Signals
Episode 3 Preview: Daniel Arbess on Purpose, Investment, and the Future of Healthcare
1:38
Ep. 2: Michelle Longmire, MD
Precision Signals
Ep. 2: Michelle Longmire, MD
55:18
AI in Oncology: Hype, Evidence, and the Threshold of Clinical Trust | Precision Signals Ep. 1
Precision Signals
AI in Oncology: Hype, Evidence, and the Threshold of Clinical Trust | Precision Signals Ep. 1
52:19